Kirsten Flowers
Director/Board Member at PMV PHARMACEUTICALS, INC.
Net worth: 799 $ as of 2024-04-29
Network origin in Kirsten Flowers first degree
Entity | Entity type | Industry | |
---|---|---|---|
Public Company | Miscellaneous Commercial Services | 18 | |
Public Company | Pharmaceuticals: Major | 13 | |
Public Company | Biotechnology | 12 | |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million.
10
| Subsidiary | Pharmaceuticals: Major | 10 |
Subsidiary | Pharmaceuticals: Major | 7 | |
ReForm Biologics LLC
ReForm Biologics LLC BiotechnologyHealth Technology ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA.
4
| Subsidiary | Biotechnology | 4 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Kirsten Flowers via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
MIRATI THERAPEUTICS | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Director of Finance/CFO | |
PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
CELGENE | Biotechnology | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Doctorate Degree Graduate Degree | |
Brown University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Founder Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Sales & Marketing Comptroller/Controller/Auditor Corporate Officer/Principal | |
ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Director of Finance/CFO Director of Finance/CFO | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
Verseau Therapeutics, Inc.
Verseau Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Verseau Therapeutics, Inc. provides immuno-therapy services. The company was founded by Daniel Anderson, Robert Langer, Igor Feldman, and Tatiana Novobrantseva in 2017 and is headquartered in Bedford, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Fordham University
Fordham University Other Consumer ServicesConsumer Services Fordham University provides college and university. It offers undergraduate colleges and graduate & professional schools. The company was founded in 1841 and is headquartered in Bronx, NY. | College/University | Masters Business Admin Masters Business Admin | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
ANAPTYSBIO, INC. | Biotechnology | Chairman Director of Finance/CFO | |
ETERNA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
Crop Enhancement LLC
Crop Enhancement LLC Chemicals: AgriculturalProcess Industries Crop Enhancement LLC develops green formulation technologies for improving agricultural production. It offers three environmental products platform: CropCoat Produce Protection, Agrochemical Encapsulatio, and Particle Stabilization. The company was founded by David Soane and Zach Jonasson in 2011 and is headquartered in Cambridge, MA. | Chemicals: Agricultural | Founder Chief Tech/Sci/R&D Officer | |
ENLIVEN THERAPEUTICS, INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
METACRINE, INC. | Biotechnology | Director/Board Member Founder | |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
ABSCI CORPORATION | Biotechnology | Director/Board Member Director of Finance/CFO | |
SPYRE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
Princeton University | College/University | Corporate Officer/Principal Undergraduate Degree | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
Terremoto Biosciences, Inc.
Terremoto Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Terremoto Biosciences, Inc. is a drug discovery and development company that creates highly targeted, small molecule medicines with unmatched selectivity, potency, and efficacy to deliver superior therapeutic benefit to patients. The company is based in San Francisco, CA. Terremoto is supported by leading investors, including OrbiMed, Third Rock Ventures, EcoR1 Capital, Novo Holdings, and Cormorant Capital. The company aims to expand the universe of drug targets and improve existing medicines by unleashing the power of covalent chemistry. Terremoto was founded by Peter A. Thompson and Matthew P. Jacobson, and Peter A. Thompson has been the CEO since incorporation. | Pharmaceuticals: Major | Founder Director/Board Member | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
The Warren Alpert Medical School | College/University | Doctorate Degree Corporate Officer/Principal | |
SHIRE | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
JANUX THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
The University of Colorado | College/University | Doctorate Degree Masters Business Admin | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree | |
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Investment Banks/Brokers | Corporate Officer/Principal Analyst-Equity | |
ATYR PHARMA, INC. | Pharmaceuticals: Major | Director/Board Member Consultant / Advisor | |
FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Kyowa Kirin Ltd.
Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | General Counsel Director/Board Member | |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Founder Corporate Officer/Principal | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree | |
Boston College | College/University | Undergraduate Degree Undergraduate Degree |
Statistics
International
United States | 49 |
Ireland | 2 |
United Kingdom | 2 |
Sectoral
Health Technology | 30 |
Consumer Services | 15 |
Finance | 4 |
Technology Services | 2 |
Commercial Services | 2 |
Operational
Director/Board Member | 255 |
Corporate Officer/Principal | 128 |
Independent Dir/Board Member | 107 |
Undergraduate Degree | 45 |
Chairman | 42 |
Most connected contacts
Insiders | |
---|---|
Peter Thompson | 39 |
Carol Gallagher | 39 |
Richard Heyman | 33 |
Arnold Levine | 30 |
Zachariah Jonasson | 25 |
Carrie Cox | 22 |
Robert Hoffman | 22 |
V. Lawlis | 21 |
Stuart Randle | 19 |
David Mack | 19 |
Thilo Schroeder | 18 |
Bridget Martell | 17 |
Shalini Sharp | 17 |
Sirshendu Roopom Banerjee | 16 |
Barbara Finck | 15 |
- Stock Market
- Insiders
- Kirsten Flowers
- Company connections